Live Breaking News & Updates on Neumora Therapeutics Daily|Page 7
Stay updated with breaking news from Neumora therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) Director Kristina Burow purchased 17,275 shares of the firm’s stock in a transaction that occurred on Friday, November 10th. The shares were acquired at an average cost of $11.49 per share, with a total value of $198,489.75. Following the completion of the transaction, the director now owns […] ....
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) major shareholder Arch Venture Partners Xii, Llc purchased 30,192 shares of the business’s stock in a transaction that occurred on Tuesday, November 7th. The stock was acquired at an average price of $11.50 per share, for a total transaction of $347,208.00. Following the acquisition, the insider now […] ....
Neumora Therapeutics (NASDAQ:NMRA – Free Report) had its price target reduced by JPMorgan Chase & Co. from $21.00 to $20.00 in a report released on Wednesday morning, Benzinga reports. They currently have an overweight rating on the stock. Other research analysts have also recently issued reports about the stock. William Blair assumed coverage on shares […] ....
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives $22.83 Consensus Target Price from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) was down 5.8% on Monday . The stock traded as low as $10.71 and last traded at $10.99. Approximately 55,605 shares changed hands during trading, a decline of 86% from the average daily volume of 408,033 shares. The stock had previously closed at $11.67. Analysts Set New […] ....